SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001140361-21-041392
Filing Date
2021-12-13
Accepted
2021-12-13 17:00:16
Documents
1
Group Members
LARRY ROBBINS

Document Format Files

Seq Description Document Type Size
1 SC 13D/A brhc10031730_sc13da.htm SC 13D/A 105302
  Complete submission text file 0001140361-21-041392.txt   107285
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Subject) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-45947 | Film No.: 211488694
SIC: 2834 Pharmaceutical Preparations

Mailing Address 767 FIFTH AVENUE 44TH FLOOR NEW YORK NY 10153
Business Address 767 FIFTH AVENUE 44TH FLOOR NEW YORK NY 10153 2128124700
GLENVIEW CAPITAL MANAGEMENT, LLC (Filed by) CIK: 0001138995 (see all company filings)

IRS No.: 134136746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A